aceclofenac has been researched along with Inflammation in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Kumar, R; Negi, S; Sharma, P; Tandel, N; Tyagi, RK | 1 |
| Katara, R; Majumdar, DK; Sachdeva, S | 2 |
| Poorvashree, J; Suneela, D | 1 |
| Basu, SK; Das, A; Jana, S; Nayak, AK; Sen, KK | 1 |
| Katare, OP; Kaur, M; Kumar, M; Kumar, P; Malik, R; Raza, K; Sharma, G | 1 |
| Boakye, CH; Godugu, C; Mendonca Faria, HA; Patel, AR; Singh, M; Somagoni, J; Zucolotto, V | 1 |
| Ganesh, M; Hemalatha, P; Jang, HT; Jeon, UJ; Peng, MM; Saravanakumar, A; Ubaidulla, U | 1 |
| Bindu, DT; Chowdary, VH; Haritha, K; Raju, YP; Satyanarayana, RP; Vandana, KR; Vinesha, V | 1 |
| Goyal, H; Katare, OP; Raza, K; Sharma, G; Thakur, K | 1 |
| Garg, NK; Goni, VG; Kapil, N; Katare, OP; Pareek, A; Raza, K; Saini, MK; Sharma, G; Thakur, K | 1 |
| Dabholkar, P; Das, V; Grawal, SP; Khattri, S; Nath, R; Nischal, A; Pant, KK; Singh, A | 1 |
| Dua, K; Pabreja, K; Padi, SS | 1 |
| Gilhotra, RM; Mathurm, M | 1 |
| Chakraborty, S; Dinda, SC; Khanam, N; Khandai, M; Patra, ChN; Sen, KK; Sharma, A | 1 |
| Dua, K; Pabreja, K; Ramana, MV | 1 |
| Katara, R; Majumdar, DK | 1 |
| Legrand, E | 1 |
| Hernandez-Vaquero, D; Sandoval, MA | 1 |
| El Shamy, AA; Mansour, S; Mortada, ND; Nasr, M | 1 |
| Henrotin, Y; Paul, I; Reginster, JY | 1 |
| Aslanidis, S; De Bast, J; Leeb, B; Lemmel, EM | 1 |
4 review(s) available for aceclofenac and Inflammation
| Article | Year |
|---|---|
Aceclofenac and methotrexate combination therapy could influence Th1/Th17 axis to modulate rheumatoid-arthritis-induced inflammation.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Drug Therapy, Combination; Inflammation; Methotrexate; Mice | 2023 |
Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Delivery Systems; Inflammation; Osteoarthritis | 2014 |
Aceclofenac in the management of inflammatory pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2004 |
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage; Chronic Disease; Diclofenac; Humans; Inflammation; Osteoarthritis; Pain; Spondylitis, Ankylosing | 2001 |
19 other study(ies) available for aceclofenac and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzyl Alcohol; Buffaloes; Chemistry, Pharmaceutical; Diclofenac; Female; Goats; Inflammation; Male; Ophthalmic Solutions; Permeability; Plant Oils; Rabbits; Sheep | 2018 |
Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Diclofenac; Drug Design; Female; Freund's Adjuvant; Hydroxychloroquine; Inflammation; Male; Mice; Prodrugs; Pyrroles; Rats; Rats, Wistar | 2017 |
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits | 2019 |
Aceclofenac-loaded unsaturated esterified alginate/gellan gum microspheres: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Carrageenan; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Polysaccharides, Bacterial; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Capsaicin; Cell Proliferation; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Emulsions; Gels; Humans; Imiquimod; Immunohistochemistry; In Vitro Techniques; Inflammation; Keratinocytes; Micelles; Microdialysis; Microscopy, Atomic Force; Nanoparticles; Organ Size; Permeability; Psoriasis; Rats; Rheology; Skin Absorption; Spleen | 2014 |
Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chitosan; Crystallization; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Particle Size; Rats; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Topics: Aloe; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Stability; Edema; Gels; Hydrogen-Ion Concentration; Inflammation; Male; Rats; Rats, Wistar; Skin Absorption; Viscosity | 2015 |
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Topics: Administration, Cutaneous; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Drug Carriers; Inflammation; Liposomes; Male; Mice; Pain; Phospholipids; Rats; Rats, Wistar; Skin; Skin Absorption | 2016 |
Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study.
Topics: Animals; Arthritis, Rheumatoid; Delayed-Action Preparations; Diclofenac; Edema; Humans; Inflammation; Liposomes; Lysine; Mice; Nanoparticles; Rats; Skin; Xylenes | 2017 |
PARFLEX--a very useful drug for management of surgical pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative | 2008 |
Evaluation of extemporaneously manufactured topical gels containing aceclofenac on inflammation and hyperalgesia in rats.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Edema; Female; Gels; Hyperalgesia; Inflammation; Male; Polyethylene Glycols; Rats; Rats, Wistar | 2010 |
Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Diclofenac; Diffusion; Dinoprostone; Eye Diseases; Gelatin; Glycerol; Inflammation; Ophthalmic Solutions; Polymers; Rabbits; Vision, Ocular | 2011 |
Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: An investigation of the effects of polymers using multiple comparison analysis.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Drug Carriers; Edema; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Pectins; Rats; Rats, Wistar; Stomach | 2010 |
Aceclofenac topical dosage forms: in vitro and in vivo characterization.
Topics: Acrylic Resins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Edema; Gels; Hyperalgesia; Hypromellose Derivatives; Inflammation; Male; Methylcellulose; Ointments; Polyethylene Glycols; Rabbits; Rats; Rats, Wistar; Skin Irritancy Tests; Solubility | 2010 |
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cornea; Diclofenac; Drug Delivery Systems; Drug Stability; Eye; Goats; Inflammation; Nanoparticles; Particle Size; Permeability; Polymers; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Suspensions; X-Ray Diffraction | 2013 |
Preventing peridural fibrosis with nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cicatrix; Connective Tissue; Diclofenac; Disease Models, Animal; Dura Mater; Epidural Space; Fibroblasts; Fibrosis; Inflammation; Laminectomy; Lumbar Vertebrae; Postoperative Complications; Rabbits; Spinal Canal; Tissue Adhesions; Treatment Outcome | 2008 |
Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Diffusion; Drug Compounding; Drug Evaluation, Preclinical; Inflammation; Liposomes; Male; Materials Testing; Rats | 2008 |
Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the manage
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cohort Studies; Diclofenac; Europe; Female; Humans; Inflammation; International Cooperation; Male; Middle Aged; Observation; Pain; Patient Compliance; Patient Satisfaction; Physicians; Practice Patterns, Physicians'; Treatment Outcome | 2002 |